Drug Interaction Report

Using PHYSostigmine together with homatropine ophthalmic may decrease the benefits of PHYSostigmine in the treatment of dementia. PHYSostigmine may also counteract the benefit of homatropine ophthalmic. Homatropine ophthalmic should generally be avoided in patients with Alzheimer's disease or other cognitive problems. Homatropine ophthalmic may also adversely affect elderly patients by producing symptoms ranging from mild thinking impairment to delirium. It is important that you tell your healthcare provider about all other medications that you are using including vitamins and herbs. Do not stop using your medications without first talking to your doctor.